ES8503247A1 - Un metodo para obtener una preparacion farmaceutica que contiene un derivado de 16 beta-etil-17 beta-hidroxi-estrano. - Google Patents

Un metodo para obtener una preparacion farmaceutica que contiene un derivado de 16 beta-etil-17 beta-hidroxi-estrano.

Info

Publication number
ES8503247A1
ES8503247A1 ES522904A ES522904A ES8503247A1 ES 8503247 A1 ES8503247 A1 ES 8503247A1 ES 522904 A ES522904 A ES 522904A ES 522904 A ES522904 A ES 522904A ES 8503247 A1 ES8503247 A1 ES 8503247A1
Authority
ES
Spain
Prior art keywords
carbon
preparation
oral cavity
androgenic
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522904A
Other languages
English (en)
Other versions
ES522904A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES8503247A1 publication Critical patent/ES8503247A1/es
Publication of ES522904A0 publication Critical patent/ES522904A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

METODO PARA OBTENER UNA PREPARACON S CONTIENE UN DERIVADO DE 16BBB-ETIL-17BBB-HIDROXI-ESTRANO, COMPUESTO ANTI-ANDROGENICAMENTE ACTIVO, Y QUE ESTA DESTINADA A SER ADMINISTRADA COLOCANDO UNA UNIDAD DE ADMINISTRACION EN LA CAVIDAD ORAL A FIN DE QUE SEA ABSORBIDA A TRAVES DE LA MEMBRANA MUCOSA ORAL. SE LOGRA UNA ABSORCION MEJORADA A TRAVES DE DICHA MEMBRANA FORMULANDO LA UNIDAD DE ADMINISTRACION DE MANERA QUE SEA CAPAZ DE RESISTR DURANTE MAS DE 30 MINUTOS EN LA CAVIDAD ORAL.
ES522904A 1982-06-02 1983-06-01 Un metodo para obtener una preparacion farmaceutica que contiene un derivado de 16 beta-etil-17 beta-hidroxi-estrano. Granted ES522904A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57095070A JPS58210007A (ja) 1982-06-02 1982-06-02 上部「あ」

Publications (2)

Publication Number Publication Date
ES8503247A1 true ES8503247A1 (es) 1985-02-16
ES522904A0 ES522904A0 (es) 1985-02-16

Family

ID=14127726

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522904A Granted ES522904A0 (es) 1982-06-02 1983-06-01 Un metodo para obtener una preparacion farmaceutica que contiene un derivado de 16 beta-etil-17 beta-hidroxi-estrano.

Country Status (7)

Country Link
EP (1) EP0095944A3 (es)
JP (1) JPS58210007A (es)
KR (1) KR840005021A (es)
DK (1) DK249083D0 (es)
ES (1) ES522904A0 (es)
GR (1) GR78809B (es)
PT (1) PT76785A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
GB8608818D0 (en) * 1986-04-11 1986-05-14 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
EP1837020A1 (en) 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856829A (en) * 1970-01-07 1974-12-24 Takeda Chemical Industries Ltd 16{62 -hydrocarbon substituted estrane compounds
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
DE3027908A1 (de) * 1980-07-21 1982-03-18 Schering Ag, 1000 Berlin Und 4619 Bergkamen 16 (beta) -ethylsteroide, diese enthaltende praeparate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0095944A2 (en) 1983-12-07
JPS58210007A (ja) 1983-12-07
GR78809B (es) 1984-10-02
DK249083D0 (da) 1983-06-01
PT76785A (en) 1983-06-01
KR840005021A (ko) 1984-11-03
ES522904A0 (es) 1985-02-16
EP0095944A3 (en) 1985-05-08

Similar Documents

Publication Publication Date Title
MY102980A (en) Transdermal flux enhancing compositions
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
ES8507444A1 (es) Un procedimiento para la preparacion de un derivado de un alcohol , -dihidropoliprenilico
ES8307496A1 (es) Procedimiento para la obtencion de una preparacion galenica antagonista al calcio.
DE3568440D1 (en) New (8s)-8-fluoroerythromycin derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
ES8503247A1 (es) Un metodo para obtener una preparacion farmaceutica que contiene un derivado de 16 beta-etil-17 beta-hidroxi-estrano.
EP0104768A3 (en) Oral compositions comprising ng-acyl derivatives of arginine
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
ES8400028A1 (es) Metodo de preparacion de una composicion tixotropica anhidra.
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
HUT37767A (en) Process for preparing isoxazole derivatives further pharmaceutical compositions containing such compounds as active substances
KR960700701A (ko) 파라세타몰 및 l-시스테인 또는 이것의 전구물질을 함유하는 약제조성물(pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof)
NO872115L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive steroider.
ES466493A1 (es) Procedimiento de fabricacion de acidos a-aril-a -oxo-isovalericos.
UA66925C2 (uk) Поліморфні форми кристалічного цитрату азабіцикло[2.2.2]-октан-3-аміну, спосіб їх одержання, фармацевтична композиція та спосіб лікування блювання
DE3369327D1 (en) Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation
NL7405118A (es)
JPS6434915A (en) Drug preparation for skin
ES421570A1 (es) Un procedimiento para la preparacion de nuevos derivados de cianopregnenona.
GB1326528A (en) Method of contraception and compositions used therein
JPS6440425A (en) Therapeutical composition for cardiac arrhythmia
ES468967A1 (es) Un procedimiento para la preparacion de d-homoesteroides
KR910002455A (ko) 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
JPS6483019A (en) Composition used in oral cavity for orthodontic therapy of tooth
ES8706651A1 (es) Un procedimiento para preparar derivados de tetrazol.